- Safety, pharmacokinetic, and functional effects of the nogo-a monoclonal antibody in amyotrophic lateral sclerosis: a randomized, first-in-human clinical trial. PloS one. 2014 Academic Article GET IT
Expanding the spectrum of monoclonal light chain deposition disease in muscle.
Muscle & nerve.
Times cited: 2
- Phase II/III randomized trial of TCH346 in patients with ALS. Neurology. 2007 Academic Article GET IT